Vitamin	B:C0042870
D	I:C0042870
deficiency	I:C0042870
and	O
interleukin	O
-	I:C0384648
17	I:C0384648
relationship	O
in	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
.	O

Vitamin	O
D	I:C0042870
deficiency	I:C0042870
and	O
interleukin	B:C0384648
-	I:C0384648
17	I:C0384648
relationship	O
in	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
.	O

Vitamin	O
D	I:C0042870
deficiency	I:C0042870
and	O
interleukin	O
-	I:C0384648
17	I:C0384648
relationship	O
in	O
severe	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	B:C0042866
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	B:C0042866
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	B:C1704258
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	B:C2603343
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	B:C1516606
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	B:C0919758
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	B:C0384648
-	I:C0384648
17	I:C0384648
(	O
interleukin	O
-	I:C0384648
17	I:C0384648
)	O
.	O

We	O
aimed	O
to	O
assess	O
Vitamin	O
D	I:C0042866
(	O
Vitamin	O
D	I:C0042866
)	O
abnormalities	O
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
(	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
)	O
,	O
to	O
study	O
its	O
association	O
with	O
clinical	O
and	O
polygraphic	O
data	O
,	O
and	O
to	O
correlate	O
VD	O
levels	I:C0919758
with	O
interleukin	O
-	I:C0384648
17	I:C0384648
(	O
interleukin	B:C0384648
-	I:C0384648
17	I:C0384648
)	O
.	O

Ninety	O
-	O
two	O
patients	O
with	O
severe	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
were	O
consecutively	O
enrolled	O
between	O
September	O
2014	O
and	O
February	O
2016	O
and	O
compared	O
to	O
age	O
-	O
,	O
sex	O
-	O
,	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
-	O
matched	O
controls	O
.	O

Ninety	O
-	O
two	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
were	O
consecutively	O
enrolled	O
between	O
September	O
2014	O
and	O
February	O
2016	O
and	O
compared	O
to	O
age	O
-	O
,	O
sex	O
-	O
,	O
and	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
-	O
matched	O
controls	O
.	O

Ninety	O
-	O
two	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
were	O
consecutively	O
enrolled	O
between	O
September	O
2014	O
and	O
February	O
2016	O
and	O
compared	O
to	O
age	O
-	O
,	O
sex	O
-	O
,	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
)	O
-	O
matched	O
controls	O
.	O

Anthropometric	B:C2598146
parameters	I:C2598146
and	O
medical	O
history	I:C0262926
were	O
collected	O
.	O

Anthropometric	O
parameters	I:C2598146
and	O
medical	B:C0262926
history	I:C0262926
were	O
collected	O
.	O

The	O
serum	B:C0428586
levels	I:C0428586
of	I:C0428586
VD	I:C0428586
and	O
interleukin	O
-	I:C2697765
17	I:C2697765
were	O
determined	O
by	O
radioimmunoassay	O
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
,	O
respectively	O
.	O

The	O
serum	O
levels	I:C0428586
of	I:C0428586
VD	I:C0428586
and	O
interleukin	B:C2697765
-	I:C2697765
17	I:C2697765
were	O
determined	O
by	O
radioimmunoassay	O
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
,	O
respectively	O
.	O

The	O
serum	O
levels	I:C0428586
of	I:C0428586
VD	I:C0428586
and	O
interleukin	O
-	I:C2697765
17	I:C2697765
were	O
determined	O
by	O
radioimmunoassay	B:C0034580
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
,	O
respectively	O
.	O

The	O
serum	O
levels	I:C0428586
of	I:C0428586
VD	I:C0428586
and	O
interleukin	O
-	I:C2697765
17	I:C2697765
were	O
determined	O
by	O
radioimmunoassay	O
and	O
enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
,	O
respectively	O
.	O

Ninety	O
-	O
two	O
severe	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
patients	O
and	O
thirty	O
controls	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Ninety	O
-	O
two	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
patients	O
and	O
thirty	O
controls	O
were	O
enrolled	O
in	O
the	O
study	B:C2603343
.	O

All	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
patients	O
had	O
VD	O
deficiency	I:C0042870
.	O

All	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
patients	O
had	O
VD	B:C0042870
deficiency	I:C0042870
.	O

The	O
mean	O
level	B:C0919758
of	I:C0919758
VD	I:C0919758
was	O
at	O
7.9	O
ng/	O
ml	O
among	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	O
versus	O
16.8	O
ng	O
/	O
ml	O
among	O
control	O
group	O
.	O

The	O
mean	O
level	O
of	I:C0919758
VD	I:C0919758
was	O
at	O
7.9	O
ng/	O
ml	O
among	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	O
versus	O
16.8	O
ng	O
/	O
ml	O
among	O
control	O
group	O
.	O

The	O
mean	O
level	O
of	I:C0919758
VD	I:C0919758
was	O
at	O
7.9	O
ng/	O
ml	O
among	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	B:C1257890
versus	O
16.8	O
ng	O
/	O
ml	O
among	O
control	O
group	O
.	O

IL	B:C2697765
-	I:C2697765
17A	I:C2697765
levels	I:C2697765
were	O
elevated	O
(	O
20.3	O
pg/ml	O
)	O
in	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	O
compared	O
to	O
healthy	O
group	I:C1257890
(	O
10.05	O
pg/ml	O
)	O
.	O

IL	O
-	I:C2697765
17A	I:C2697765
levels	I:C2697765
were	O
elevated	O
(	O
20.3	O
pg/ml	O
)	O
in	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	O
compared	O
to	O
healthy	O
group	I:C1257890
(	O
10.05	O
pg/ml	O
)	O
.	O

IL	O
-	I:C2697765
17A	I:C2697765
levels	I:C2697765
were	O
elevated	O
(	O
20.3	O
pg/ml	O
)	O
in	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	B:C1257890
compared	O
to	O
healthy	O
group	I:C1257890
(	O
10.05	O
pg/ml	O
)	O
.	O

IL	O
-	I:C2697765
17A	I:C2697765
levels	I:C2697765
were	O
elevated	O
(	O
20.3	O
pg/ml	O
)	O
in	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
group	O
compared	O
to	O
healthy	B:C1257890
group	I:C1257890
(	O
10.05	O
pg/ml	O
)	O
.	O

VD	B:C0919758
levels	I:C0919758
were	O
negatively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

VD	O
levels	I:C0919758
were	O
negatively	B:C1513916
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

VD	O
levels	I:C0919758
were	O
negatively	O
correlated	O
with	O
nocturia	B:C0028734
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

VD	O
levels	I:C0919758
were	O
negatively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	B:C1514241
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

VD	O
levels	I:C0919758
were	O
negatively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	O
correlated	O
with	O
mean	O
O2	B:C0523807
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

VD	O
levels	I:C0919758
were	O
negatively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
-	O
0.26	O
;	O
P	O
=	O
0.01	O
)	O
and	O
positively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
0.59	O
;	O
P	O
=	O
0.02	O
)	O
and	O
lowest	O
O2	B:C0523807
saturation	I:C0523807
(	O
r	O
=	O
0.3	O
;	O
P	O
=	O
0.03	O
)	O
.	O

IL	B:C2697765
-	I:C2697765
17	I:C2697765
levels	I:C2697765
were	O
positively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
0.24	O
;	O
P	O
=	O
0.03	O
)	O
and	O
negatively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
-	O
0.42	O
;	O
P	O
=	O
0.03	O
)	O
.	O

IL	O
-	I:C2697765
17	I:C2697765
levels	I:C2697765
were	O
positively	B:C1514241
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
0.24	O
;	O
P	O
=	O
0.03	O
)	O
and	O
negatively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
-	O
0.42	O
;	O
P	O
=	O
0.03	O
)	O
.	O

IL	O
-	I:C2697765
17	I:C2697765
levels	I:C2697765
were	O
positively	O
correlated	O
with	O
nocturia	B:C0028734
severity	O
(	O
r	O
=	O
0.24	O
;	O
P	O
=	O
0.03	O
)	O
and	O
negatively	O
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
-	O
0.42	O
;	O
P	O
=	O
0.03	O
)	O
.	O

IL	O
-	I:C2697765
17	I:C2697765
levels	I:C2697765
were	O
positively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
0.24	O
;	O
P	O
=	O
0.03	O
)	O
and	O
negatively	B:C1513916
correlated	O
with	O
mean	O
O2	O
saturation	I:C0523807
(	O
r	O
=	O
-	O
0.42	O
;	O
P	O
=	O
0.03	O
)	O
.	O

IL	O
-	I:C2697765
17	I:C2697765
levels	I:C2697765
were	O
positively	O
correlated	O
with	O
nocturia	O
severity	O
(	O
r	O
=	O
0.24	O
;	O
P	O
=	O
0.03	O
)	O
and	O
negatively	O
correlated	O
with	O
mean	O
O2	B:C0523807
saturation	I:C0523807
(	O
r	O
=	O
-	O
0.42	O
;	O
P	O
=	O
0.03	O
)	O
.	O

A	O
significant	O
negative	B:C1513916
association	I:C1513916
was	O
observed	O
between	O
IL	O
-	I:C2697765
7	I:C2697765
and	O
VD	O
levels	I:C0919758
(	O
r	O
=	O
-	O
0.64	O
,	O
P	O
=	O
0.2	O
10	O
(	O
-	O
4	O
)	O
)	O
.	O

A	O
significant	O
negative	O
association	I:C1513916
was	O
observed	O
between	O
IL	B:C2697765
-	I:C2697765
7	I:C2697765
and	O
VD	O
levels	I:C0919758
(	O
r	O
=	O
-	O
0.64	O
,	O
P	O
=	O
0.2	O
10	O
(	O
-	O
4	O
)	O
)	O
.	O

A	O
significant	O
negative	O
association	I:C1513916
was	O
observed	O
between	O
IL	O
-	I:C2697765
7	I:C2697765
and	O
VD	B:C0919758
levels	I:C0919758
(	O
r	O
=	O
-	O
0.64	O
,	O
P	O
=	O
0.2	O
10	O
(	O
-	O
4	O
)	O
)	O
.	O

The	O
magnitude	O
of	O
this	O
correlation	O
was	O
higher	O
for	O
important	O
nocturia	B:C0028734
,	O
lower	O
MSaO2	O
,	O
or	O
higher	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

The	O
magnitude	O
of	O
this	O
correlation	O
was	O
higher	O
for	O
important	O
nocturia	O
,	O
lower	O
MSaO2	B:C0428175
,	O
or	O
higher	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

The	O
magnitude	O
of	O
this	O
correlation	O
was	O
higher	O
for	O
important	O
nocturia	O
,	O
lower	O
MSaO2	O
,	O
or	O
higher	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
.	O

VD	B:C0042870
deficiency	I:C0042870
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
is	O
common	O
with	O
a	O
negative	O
association	I:C1513916
between	O
interleukin	O
-	I:C0384648
17	I:C0384648
and	O
VD	O
serum	I:C0428586
levels	I:C0428586
.	O

VD	O
deficiency	I:C0042870
in	O
patients	O
with	O
severe	O
obstructive	B:C4285910
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
is	O
common	O
with	O
a	O
negative	O
association	I:C1513916
between	O
interleukin	O
-	I:C0384648
17	I:C0384648
and	O
VD	O
serum	I:C0428586
levels	I:C0428586
.	O

VD	O
deficiency	I:C0042870
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
is	O
common	O
with	O
a	O
negative	B:C1513916
association	I:C1513916
between	O
interleukin	O
-	I:C0384648
17	I:C0384648
and	O
VD	O
serum	I:C0428586
levels	I:C0428586
.	O

VD	O
deficiency	I:C0042870
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
is	O
common	O
with	O
a	O
negative	O
association	I:C1513916
between	O
interleukin	B:C0384648
-	I:C0384648
17	I:C0384648
and	O
VD	O
serum	I:C0428586
levels	I:C0428586
.	O

VD	O
deficiency	I:C0042870
in	O
patients	O
with	O
severe	O
obstructive	O
sleep	I:C4285910
apnea	I:C4285910
-	I:C4285910
hypopnea	I:C4285910
syndrome	I:C4285910
is	O
common	O
with	O
a	O
negative	O
association	I:C1513916
between	O
interleukin	O
-	I:C0384648
17	I:C0384648
and	O
VD	B:C0428586
serum	I:C0428586
levels	I:C0428586
.	O

Hypoxia	B:C0242184
could	O
play	O
an	O
important	O
role	O
in	O
this	O
association	O
.	O

Further	O
studies	B:C2603343
are	O
needed	O
to	O
clarify	O
this	O
relationship	O
.	O

